相关实验视频

Updated: Jun 30, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

长非编码RNAs在充血性心力衰竭中对线粒体功能的调节机制

Changjin Li¹, Mingyao Zhou¹, Xiaowei Song¹

¹Department of Cardiology, Changhai Hospital, Naval Medical University, No. 168, Changhai Road, Yangpu District, Shanghai, 200433, China.

Non-coding RNA research

|March 18, 2024

概括

长非编码RNAs (lncRNAs) 调节线粒体功能,这是心力衰竭的关键因素. 这篇评论探讨了 lncRNAs.

科学领域:

心血管疾病心血管疾病
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

由于有效治疗方法有限,充血性心力衰竭 (CHF) 存在重大挑战.
线粒体功能障碍是心力衰竭中心脏能量供应受损的主要驱动因素.
长非编码RNAs (lncRNAs) 越来越多地被认为是它们在调节细胞过程中的作用,包括心脏中的过程.

研究的目的:

通过新型 lncRNAs 对线粒体功能调节机制的当前研究进行审查.
确定临床研究和心力衰竭治疗的潜在新目标.
探索lncRNA,线粒体活动和心脏功能障碍之间的联系.

主要方法:

关于心力衰竭中 lncRNAs 和线粒体功能的最新研究的文献综述.
分析lncRNA在基因转录,翻译和翻译后修改中的调节作用.
检查线粒体基因组编码的lncRNAs及其对心脏能量生产的影响.

主要成果:

lncRNAs通过调节基因表达和线粒体活动,显著影响心脏病理生理学.
由氧化应激和不平衡等因素加剧的线粒体损伤与心力衰竭直接相关.
新的lncRNA正在成为线粒体功能的关键调节者,影响ATP生产和心脏能量供应.

结论:

lncRNAs代表了理解和治疗心力衰竭的一个有希望的领域.
针对线粒体功能的IncRNA介导调节可能为CHF提供新的治疗策略.
对特定的lncRNA及其分子通路的进一步研究对于临床翻译至关重要.

关键词:

充血性心力衰竭是因为长的非编码RNA是什么?线粒体中的线粒体.

更多相关视频

Author Spotlight: Uncovering the Role of Mitochondrial Calcium Phosphate in Heart Failure and Bioenergetics

Author Spotlight: Uncovering the Role of Mitochondrial Calcium Phosphate in Heart Failure and Bioenergetics

Published on: August 23, 2024

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer

Published on: February 13, 2019

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Types of RNA

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Formation of Muscle Fibers from Myoblasts

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...